Skip to search formSkip to main contentSkip to account menu

Janus Kinase Inhibitors [MoA]

Known as: Janus Kinase Inhibitors 
National Institutes of Health

Related topics

Related topics

2 relations
tofacitinibtofacitinib 5 MG Oral Tablet

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
4CPS-119 ‘Real world’ experience of tofacitinib and baricitinib in the treatment of rheumatoid arthritis: effectiveness and safety evaluation
Background and importance Tofacitinib and baricitinib are oral Janus kinase inhibitors (JKi) approved for the treatment of… 
2019
2019
THU0026 TARGETING SYNOVIAL FIBROBLASTS IN RHEUMATOID ARTHRITIS BY PEFICITINIB AND FILGOTINIB
Background The Janus kinase inhibitors (JAKi) peficitinib and filgotinib are currently examined in clinical trials for treatment… 
2019
2019
FRI0077 SHORT DURATION OF CONVENTIONAL SYNTHETIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS (CSDMARDS) BEFORE AND AFTER BECOMING A CSDMARD INADEQUATE RESPONDER IN RHEUMATOID ARTHRITIS PATIENTS
Background ACR guidelines recommend starting rheumatoid arthritis (RA) treatment with conventional-synthetic (cs)DMARD… 
2018
2018
FRI0257 The stat4 sle risk allele rs7574865[t] is associated with increased il-12-induced ifn-gamma production in t cells from sle patients
Background Genetic variants in the transcription factor STAT4 are associated with increased susceptibility to systemic lupus… 
2018
2018
P117 Effect of different janus kinase inhibitors on fibroblast-like synoviocytes in rheumatoid arthritis
Introduction In 2017, the Janus kinase inhibitors (JAKi) Tofacitinib and Baricitinib were approved for the treatment of… 
2016
2016
THU0182 Ex Vivo Functional Comparison of Baricitinib and Tofacitinib for Cytokine Signaling in Human Leukocyte Subpopulations
Background Baricitinib (bari) and tofacitinib (tofa) are selective JANUS kinase inhibitors (JAKi). In biochemical assays, bari… 
Review
2015
Review
2015
Novel agents for the treatment of Hodgkin lymphoma
Hodgkin lymphoma (HL) is highly curable lymphoma with combined multiagent chemotherapy with or without radiation. In spite of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)